PHILOMENE GOUELIANI: Open Payments
NPI 1891102885 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 37 payments from 8 companies in 2025. Trend: 2023 $171 · 2024 $297 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $327 |
| Axsome Therapeutics, Inc. | 6 | $146 |
| Ardelyx, Inc. | 3 | $94 |
| ABBVIE INC. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| PFIZER INC. | 2 | $51 |
| Novo Nordisk Inc | 2 | $46 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: Symbravo, IBSRELA, MAVYRET, BREZTRI, Ozempic, NURTEC ODT, PREVNAR 20, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
